Class I and III phosphatidylinositol 3'-kinase play distinct roles in TLR signaling pathway

被引:59
|
作者
Kuo, Cheng-Chin
Lin, Wen-Ting
Liang, Chi-Ming
Liang, Shu-Mei
机构
[1] Acad Sinica, Inst Bioagr Sci, Taipei, Taiwan
[2] Acad Sinica, Inst Biol Chem, Taipei, Taiwan
[3] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan
来源
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷 / 10期
关键词
D O I
10.4049/jimmunol.176.10.5943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PI3K involvement has been implicated in the TLR signal pathway. However, the precise roles of the different classes of PI3K in the pathway remain elusive. In this study, we have explored the functions of class I and class III PI3K in the TLR signal pathway using specific kinase mutants and PI3K lipid products. Our results reveal that class III PI3K specifically regulates CpG oligode-oxynucleotide (ODN)-induced cytokine and NO production as well as NF-kappa B activation, whereas class I PI3K regulates both CpG ODN- and LPS-induced IL-12 production and NF-kappa B activation. Additional studies of CpG ODN uptake with flow cytometric analysis show that class III PI3K, but not class 1, regulates cellular CpG ODN uptake. Furthermore, experiments with MyD88-overexpressing fibroblast cells transfected with dominant-negative mutants of PI3K demonstrate that class III PI3K regulates CpG ODN-mediated signaling upstream of MyD88, while class I PI3K regulation is downstream of MyD88. These results suggest that class I and class III PI3K play distinct roles in not only the uptake of CpG ODN, but also responses elicited by CpG ODN and LPS.
引用
收藏
页码:5943 / 5949
页数:7
相关论文
共 50 条
  • [31] Inhibition of the phosphatidylinositol 3′-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac
    Yip-Schneider, MT
    Wiesenauer, CA
    Schmidt, CM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (03) : 354 - 363
  • [32] Survival of porcine granulosa cells is mediated by a phosphatidylinositol-3-kinase (PI-3-kinase) signaling pathway.
    Westfall, SD
    Fong, HW
    Rueda, BR
    Davis, JS
    BIOLOGY OF REPRODUCTION, 1998, 58 : 113 - 113
  • [33] The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells
    Kamei, T
    Jones, SR
    Chapman, BM
    McGonigle, KL
    Dai, GL
    Soares, MJ
    MOLECULAR ENDOCRINOLOGY, 2002, 16 (07) : 1469 - 1481
  • [34] Inhibition of the phosphatidylinositol 3’-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac
    Michele T. Yip-Schneider
    Chad A. Wiesenauer
    C. Max Schmidt
    Journal of Gastrointestinal Surgery, 2003, 7 : 354 - 363
  • [35] Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme
    Ruano, Yolanda
    Mollejo, Manuela
    Camacho, Francisca I.
    de Lope, Angel Rodriguez
    Fiano, Concepcion
    Ribalta, Teresa
    Martinez, Pedro
    Hernandez-Moneo, Jose-Luis
    Melendez, Barbara
    CANCER, 2008, 112 (07) : 1575 - 1584
  • [36] RhoA controls myoblast survival by inducing the phosphatidylinositol 3-kinase-Akt signaling pathway
    Reuveny, M
    Heller, H
    Bengal, E
    FEBS LETTERS, 2004, 569 (1-3): : 129 - 134
  • [37] Putative role of the phosphatidylinositol 3-kinase-Akt signaling pathway in the survival of granulosa cells
    Westfall, SD
    Hendry, IR
    Obholz, KL
    Rueda, BR
    Davis, JS
    ENDOCRINE, 2000, 12 (03) : 315 - 321
  • [38] Putative role of the phosphatidylinositol 3-kinase — Akt signaling pathway in the survival of granulosa cells
    Suzanne D. Westfall
    Isabel R. Hendry
    Kevin L. Obholz
    Bo R. Rueda
    John S. Davis
    Endocrine, 2000, 12 : 315 - 321
  • [39] Inhibition of transforming growth factor-β/Smad signaling by phosphatidylinositol 3-kinase pathway
    Qiao, Jingbo
    Kang, Junghee
    Ko, Tien C.
    Evers, B. Mark
    Chung, Dai H.
    CANCER LETTERS, 2006, 242 (02) : 207 - 214
  • [40] Components of the JNK–MAPK pathway play distinct roles in hepatocellular carcinoma
    Jijun Yu
    Xinying Li
    Junxia Cao
    Ting Zhu
    Shuifeng Liang
    Le Du
    Meng Cao
    Haitao Wang
    Yaolin Zhang
    Yinxi Zhou
    Beifen Shen
    Jiannan Feng
    Jiyan Zhang
    Jing Wang
    Jianfeng Jin
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 17495 - 17509